Herbal antitumor formulation exhibiting anticancerous activity against breast cancer, comprises mixture of Synadenium grantii's ethyl acetate leaf extract and dichloromethane bark extract, microcrystalline cellulose, polyvinylpyrolidene k-30, talc, colloidal silicone dioxide, sodium croscarmellose
2023-10-11
专利权人UNIV SHOOLINI BIOTECHNOLOGY & MANAGEMENT (USLN-C)
申请日期2023-10-11
专利号IN202311068100-A
成果简介NOVELTY - Herbal antitumor formulation, comprises: mixture of Synadenium grantii's 50 % ethyl acetate leaf extract and 100% dichloromethane bark extract; (b) excipient: 173-261 wt.% microcrystalline cellulose, 5-34 wt.% polyvinylpyrolidene k-30, 40-57 wt.% talc, 5 wt.% colloidal silicone dioxide, and 5-29 wt.% sodium croscarmellose, where Synadenium grantiiextracts includes petroleum ether, dichloromethane, ethyl acetate, acetone and ethanol. USE - Herbal antitumor formulation exhibiting anticancerous or antitumor activity against breast cancer cell line MCF-7 (all claimed). Test details are described but no results given. ADVANTAGE - The formulation exhibits enhanced efficacy, low toxicity, and cost-effective treatment; reduce toxicity; exhibit synergistic effects; and is environment-friendly, natural, and safe.
IPC 分类号A61K-036/185 ; A61K-036/282 ; A61K-036/47 ; A61K-036/484 ; A61P-035/00 ; A61P-005/28
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20039
专题中国科学院新疆生态与地理研究所
作者单位
UNIV SHOOLINI BIOTECHNOLOGY & MANAGEMENT (USLN-C)
推荐引用方式
GB/T 7714
PUNDIR S,DAS I. Herbal antitumor formulation exhibiting anticancerous activity against breast cancer, comprises mixture of Synadenium grantii's ethyl acetate leaf extract and dichloromethane bark extract, microcrystalline cellulose, polyvinylpyrolidene k-30, talc, colloidal silicone dioxide, sodium croscarmellose. IN202311068100-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。